Infectious Bovine Rhinotracheitis Virus, Passage C-13;Bovine Viral Diarrhea Viru
10 adverse event reports submitted to the FDA
Important: Adverse event reports do not establish that a drug caused or contributed to the event. Consult your veterinarian before making treatment decisions.
10
Total Reports
9
Deaths Reported
9000.0%
Death Rate
Active Ingredients
Infectious Bovine Rhinotracheitis Virus, Passage C-13;Bovine Viral Diarrhea Viru
Administration Routes
SubcutaneousIntramuscularUnknown
Species Affected
Cattle 10
Most Affected Breeds
Mixed (Cattle) 10
Most Reported Reactions
Death 7
Lack of efficacy - NOS 4
Lack of efficacy (bacteria) - NOS 3
Unrelated death 1
INEFFECTIVE, ANTIBIOTIC 1
Other abnormal test result NOS 1
CULTURE/TITER DATA ABNORMAL 1
Generalised allergic reaction NOS 1
Local swelling (not application site) 1
Dyspnoea 1
Respiratory sound 1
Unexplained death 1
Outcome Breakdown
Died
9 (47.4%)
Outcome Unknown
8 (42.1%)
Ongoing
1 (5.3%)
Recovered with Sequela
1 (5.3%)
Source: FDA Center for Veterinary Medicine — Adverse Event Reports. Data reflects voluntary submissions and may not represent actual incidence rates.